Anemia in the elderly: a consequence of aging?

Expert Review of Hematology

Volumn 10, Issue 4, 2017, Pages 327-335

  Halawi, Racha ^a   Moukhadder, Hassan ^b   Taher, Ali ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

anemia; Anemia in the elderly; anemia of chronic disease; anemia of chronic kidney disease; iron deficiency anemia; unexplained anemia

Indexed keywords

ANTIANEMIC AGENT; HEPCIDIN;

AGED; AGING; ANEMIA; BLOOD TRANSFUSION; CHRONIC DISEASE; CHRONIC KIDNEY FAILURE; DRUG SAFETY; GERIATRIC PATIENT; HUMAN; IDIOPATHIC DISEASE; IRON DEFICIENCY ANEMIA; NUTRITIONAL DEFICIENCY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; AGE; HEALTH CARE QUALITY; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PREVALENCE; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ANEMIA; COMBINED MODALITY THERAPY; HUMANS; PATIENT OUTCOME ASSESSMENT; PREVALENCE; STANDARD OF CARE;

EID: 85016325159     PISSN: 17474086     EISSN: 17474094     Source Type: Journal    
DOI: 10.1080/17474086.2017.1285695     Document Type: Review

References (91)

1. Orimo H, Ito H, Suzuki T, et al. Reviewing the definition of “elderly”. Geriatr Gerontol Int. 2006;6:149–158.
2. Organisation WH. Definition of an older or elderly person Geneva, Switzerland2010 [12/05/2016]. Available from:http://www.who.int/healthinfo/survey/ageingdefnolder/en/index.html
3. Thomas DR., Anemia and quality of life:unrecognized and undertreated. J Gerontol A Biol Sci Med Sci. 2004;59:238–241. Epub 2004/03/20.
4. Chaves PH, Semba RD, Leng SX, et al. Impact of anemia and cardiovascular disease on frailty status of community-dwelling older women:the women’s health and aging studies I and II. J Gerontol A Biol Sci Med Sci. 2005;60:729–735. Epub 2005/06/29.
5. Penninx BW, Pahor M, Cesari M, et al. Anemia is associated with disability and decreased physical performance and muscle strength in the elderly. J Am Geriatr Soc. 2004;52:719–724. Epub 2004/04/17.
6. Denny SD, Kuchibhatla MN, Cohen HJ. Impact of anemia on mortality, cognition, and function in community-dwelling elderly. Am J Med. 2006;119:327–334. Epub 2006/03/28.
7. Culleton BF, Manns BJ, Zhang J, et al. Impact of anemia on hospitalization and mortality in older adults. Blood. 2006;107:3841–3846. Epub 2006/01/13.
8. Zakai NA, Katz R, Hirsch C, et al. A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort:the cardiovascular health study. Arch Intern Med. 2005;165:2214–2220. Epub 2005/10/26.
9. Endres HG, Wedding U, Pittrow D, et al. Prevalence of anemia in elderly patients in primary care:impact on 5-year mortality risk and differences between men and women. Curr Med Res Opin. 2009;25:1143–1158. Epub 2009/03/26.
10. Dong X, Mendes De Leon C, Artz A, et al. A population-based study of hemoglobin, race, and mortality in elderly persons. J Gerontol A Biol Sci Med Sci. 2008;63:873–878. Epub 2008/09/06.
11. Penninx BW, Pahor M, Woodman RC, et al. Anemia in old age is associated with increased mortality and hospitalization. J Gerontol A Biol Sci Med Sci. 2006;61:474–479. Epub 2006/05/25.
12. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes:insights from a cohort of 12 065 patients with new-onset heart failure. Circulation. 2003;107:223–225. Epub 2003/01/23.
13. Sabatine MS, Morrow DA, Giugliano RP, et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation. 2005;111:2042–2049. Epub 2005/04/13.
14. Go AS, Yang J, Ackerson LM, et al. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure:the anemia in chronic heart failure:outcomes and resource utilization (ANCHOR) study. Circulation. 2006;113:2713–2723. Epub 2006/06/07.
15. Muzzarelli S, Pfisterer M. Anemia as independent predictor of major events in elderly patients with chronic angina. Am Heart J. 2006;152:991–996. Epub 2006/10/31.
16. Caro JJ, Salas M, Ward A, et al. Anemia as an independent prognostic factor for survival in patients with cancer:a systemic, quantitative review. Cancer. 2001;91:2214–2221. Epub 2001/06/20.
17. Zakai NA, French B, Arnold AM, et al. Hemoglobin declinefunction and mortality in the elderly:the cardiovascular health study. Am J Hematol. 2013;88. DOI:10.1002/ajh.23336
18. Artz AS, Fergusson D, Drinka PJ, et al. Prevalence of anemia in skilled-nursing home residents. Arch Gerontol Geriatr. 2004;39:201–206. Epub 2004/09/24.
19. Nathavitharana RL, Murray JA, D’Sousa N, et al. Anaemia is highly prevalent among unselected internal medicine inpatients and is associated with increased mortality, earlier readmission and more prolonged hospital stay:an observational retrospective cohort study. Intern Med J. 2012;42:683–691. Epub 2011/07/28.
20. Izaks GJ, Westendorp RJ, Knook DL. THe definition of anemia in older persons. Jama. 1999;281:1714–1717.
21. Patel KV, Harris TB, Faulhaber M, et al. Racial variation in the relationship of anemia with mortality and mobility disability among older adults. Blood. 2007;109:4663–4670. Epub 2007/02/08.
22. Landi F, Russo A, Danese P, et al. Anemia status, hemoglobin concentration, and mortality in nursing home older residents. J Am Med Dir Assoc. 2007;8:322–327.
23. Nutritional anaemias. Report of a WHO scientific group. World Health Organization technical report series. 1968;405:5–37. Epub 1968/01/01.
24. Beutler E, Waalen J. The definition of anemia:what is the lower limit of normal of the blood hemoglobin concentration? Blood. 2006;107:1747–1750. Epub 2005/09/29.• This research article defines new thresholds for the definition of anemia in the population based on two large epidemiologic studies, namely the Scripps-Kaiser and the NHANES-III databases.
25. Beutler E, Lichtman MA, Coller BS, et al. U. S. Williams hematology. New York, NY:McGraw-Hill; 2001.
26. FoersterJ GRL, LukensJ FP, GreerJP GMR. Wintrobe’s clinicalhematology. Baltimore, MD:Williams and Wilkins; 1998.
27. Si R. Introduction to Hematology. Philadelphia, PA:JB Lippincott Company; 1987.
28. Re G. Hematology. A comprehensive guide to the diagnosis and treatment of blood disorders. Los Angeles, CA:Practice Management Information Corporation (PMIC); 1997.
29. Nw T. Clinical guide to laboratory tests. Philadelphia, PA:WB Saunders Co; 1995.
30. Hoffman R, Benz EJ Jr, Shattil SJ, et al. Hematology:basic principles and practice. NewYork, NY:Churchill-Livingstone; 2004.
31. Beutler E, West C. Hematologic differences between African-Americans and whites:the roles of iron deficiency and alpha-thalassemia on hemoglobin levels and mean corpuscular volume. Blood. 2005;106:740–745. Epub 2005/03/26.
32. Guralnik JM, Eisenstaedt RS, Ferrucci L, et al. Prevalence of anemia in persons 65 years and older in the United States:evidence for a high rate of unexplained anemia. Blood. 2004;104:2263–2268. Epub 2004/07/09.•• This research article describes the prevalence and causes of anemia in the elderly population based on an analysis of the large NHANES III database.
33. Inelmen EM, D’Alessio M, Gatto MR, et al. Descriptive analysis of the prevalence of anemia in a randomly selected sample of elderly people living at home:some results of an Italian multicentric study. Aging (Milano). 1994;6:81–89. Epub 1994/04/01.
34. Salive ME, Cornoni-Huntley J, Guralnik JM, et al. Anemia and hemoglobin levels in older persons:relationship with age, gender, and health status. J Am Geriatr Soc. 1992;40:489–496. Epub 1992/05/01.
35. Robinson B, Artz AS, Culleton B, et al. Prevalence of anemia in the nursing home:contribution of chronic kidney disease. J Am Geriatr Soc. 2007;55:1566–1570. Epub 2007/08/31.
36. Migone De Amicis M, Poggiali E, Motta I, et al. Anemia in elderly hospitalized patients:prevalence and clinical impact. Intern Emerg Med. 2015;10:581–586.
37. Tettamanti M, Lucca U, Gandini F, et al. Prevalence, incidence and types of mild anemia in the elderly:the “health and anemia” population-based study. Haematologica. 2010;95:1849–1856. Epub 2010/06/11.
38. Artz AS, Thirman MJ. Unexplained anemia predominates despite an intensive evaluation in a racially diverse cohort of older adults from a referral anemia clinic. J Gerontol A Biol Sci Med Sci. 2011;66:925–932. Epub 2011/06/11.
39. Price EA, Mehra R, Holmes TH, et al. Anemia in older persons:etiology and evaluation. Blood Cells Mol Dis. 2011;46:159–165. Epub 2011/01/07.
40. McLean E, Cogswell M, Egli I, et al. Worldwide prevalence of anaemia, WHO vitamin and mineral nutrition information system, 1993-2005. Public Health Nutr. 2009;12:444–454. Epub 2008/05/24.
41. Gordon SR, Smith RE, Power GC. The role of endoscopy in the evaluation of iron deficiency anemia in patients over the age of 50. Am J Gastroenterol. 1994;89:1963–1967. Epub 1994/11/01.
42. Rockey DC, Cello JP. Evaluation of the gastrointestinal tract in patients with iron-deficiency anemia. N Engl J Med. 1993;329:1691–1695. Epub 1993/12/02.
43. Joosten E, Ghesquiere B, Linthoudt H, et al. Upper and lower gastrointestinal evaluation of elderly inpatients who are iron deficient. Am J Med. 1999;107:24–29. Epub 1999/07/14.
44. Lopez A, Cacoub P, Macdougall IC, et al. Iron deficiency anaemia. Lancet (London, England). 2016;387:907–916. Epub 2015/09/01.•• This article reviews commonly used criteria to diagnose iron deficiency anemia and to differentiate it from anemia of chronic disease.
45. Mast AE, Blinder MA, Gronowski AM, et al. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clinical Chemistry. 1998;44:45–51. Epub 1998/04/29.
46. Skikne BS, Punnonen K, Caldron PH, et al. Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia:a prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index. Am J Hematol. 2011;86:923–927. Epub 2011/08/04.
47. Loikas S, Koskinen P, Irjala K, et al. Vitamin B12 deficiency in the aged:a population-based study. Age Ageing. 2007;36:177–183. Epub 2006/12/26.
48. Andres E, Federici L, Serraj K, et al. Update of nutrient-deficiency anemia in elderly patients. Eur J Intern Med. 2008;19:488–493. Epub 2008/11/18.
49. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352:1011–1023. Epub 2005/03/11.
50. Goodnough LT. Iron deficiency syndromes and iron-restricted erythropoiesis (CME). Transfusion. 2012;52:1584–1592. Epub 2012/01/04.
51. Makipour S, Kanapuru B, Ershler WB. Unexplained anemia in the elderly. Semin Hematol. 2008;45:250–254. Epub 2008/09/24.
52. Gowanlock Z, Sriram S, Martin A, et al. Erythropoietin levels in elderly patients with anemia of unknown etiology. Plos One. 2016;11:e0157279. Epub 2016/06/17.
53. Sriram S, Xenocostas A, Lazo-Langner A. Erythropoietin in anemia of unknown etiology:A systematic review and meta-analysis. Hematology. 2016;21:234–240. Epub 2016/01/10.
54. Goodnough LT, Schrier SL. Evaluation and management of anemia in the elderly. Am J Hematol. 2014;89:88–96. Epub 2013/10/15.
55. Busti F, Campostrini N, Martinelli N, et al. Iron deficiency in the elderly population, revisited in the hepcidin era. Front Pharmacol. 2014;5.
56. Clark SF. Iron deficiency anemia:diagnosis and management. Curr Opin Gastroenterol. 2009;25:122–128. Epub 2009/03/06.
57. Pasricha SR, Flecknoe-Brown SC, Allen KJ, et al. Diagnosis and management of iron deficiency anaemia:a clinical update. Med J Aust. 2010;193:525–532. Epub 2010/11/03.
58. Silverstein SB, Rodgers GM. Parenteral iron therapy options. Am J Hematol. 2004;76:74–78. Epub 2004/04/29.
59. Auerbach M, Goodnough LT, Shander A. Iron:the new advances in therapy. Best Pract Res Clin Anaesthesiol. 2013;27:131–140. Epub 2013/04/18.
60. Auerbach M, Ballard H. Clinical use of intravenous iron:administration, efficacy, and safety. Hematol Am Soc Hematol Educ Program. 2010:338–347. Epub 2011/01/18.
61. Fernández-Real JM, Manco M. Effects of iron overload on chronic metabolic diseases. Lancet Diabetes Endocrinol. 2014;2:513–526.
62. Temraz S, Santini V, Musallam K, et al. Iron overload and chelation therapy in myelodysplastic syndromes. Crit Rev Oncol Hematol. 2014;91:64–73. Epub 2014/02/18.
63. Vidal-Alaball J, Butler CC, Cannings-John R, et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev. 2005:Cd004655. Epub 2005/07/22.
64. Sanz-Cuesta T, Gonzalez-Escobar P, Riesgo-Fuertes R, et al. Oral versus intramuscular administration of vitamin B12 for the treatment of patients with vitamin B12 deficiency:a pragmatic, randomised, multicentre, non-inferiority clinical trial undertaken in the primary healthcare setting (project OB12). BMC Public Health. 2012;12:394. Epub 2012/06/02.
65. Paoletti E, Cannella G. Update on erythropoietin treatment:should hemoglobin be normalized in patients with chronic kidney disease? J Am Soc Nephrology:JASN. 2006;17:S74–7. Epub 2006/03/28.
66. Kidney disease:improving global outcomes (KDIGO) anemia work group. KDIGO clinical practice guidelines for anemia in chronic kidney disease. Kidney Int Suppl. 2:279–335.
67. Palmer SC, Navaneethan SD, Craig JC, et al. Meta-analysis:erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med. 2010;153:23–33. Epub 2010/05/05.
68. Palmer SC, Saglimbene V, Mavridis D, et al. Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease:a network meta-analysis. Cochrane Database Syst Rev. 2014:Cd010590. Epub 2014/12/09.
69. Agnihotri P, Telfer M, Butt Z, et al. Chronic anemia and fatigue in elderly patients:results of a randomized, double-blind, placebo-controlled, crossover exploratory study with epoetin alfa. J Am Geriatr Soc. 2007;55:1557–1565. Epub 2007/08/19.
70. Ross SD, Allen IE, Probst CA, et al. Efficacy and safety of erythropoiesis-stimulating proteins in myelodysplastic syndrome:a systematic review and meta-analysis. Oncologist. 2007;12:1264–1273. Epub 2007/10/27.
71. Rizzo JD, Brouwers M, Hurley P, et al. American society of hematology/american society of clinical oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. Blood. 2010;116:4045–4059. Epub 2010/10/27.
72. Hamm CW, Bassand JP, Agewall S, et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation:the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European society of cardiology (ESC). Eur Heart J. 2011;32:2999–3054. Epub 2011/08/30.
73. Ferraris VA, Brown JR, Despotis GJ, et al. 2011 Update to the society of thoracic surgeons and the society of cardiovascular anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg. 2011;91:944–982. Epub 2011/03/01.
74. National blood authority Australia. Patient blood management guidelines. [10/15/2016]. Available from:https://www.blood.gov.au/pbm-guidelines.
75. Retter A, Wyncoll D, Pearse R, et al. Guidelines on the management of anaemia and red cell transfusion in adult critically ill patients. Br J Haematol. 2013;160:445–464. Epub 2013/01/03.
76. Qaseem A, Humphrey LL, Fitterman N, et al. Treatment of anemia in patients with heart disease:a clinical practice guideline from the American college of physicians. Ann Intern Med. 2013;159:770–779. Epub 2013/12/04.
77. Practice guidelines for perioperative blood management:an updated report by the American society of anesthesiologists task force on perioperative blood management. Anesthesiology. 2015;122:241–275. Epub 2014/12/30.
78. NCCN clinical practice guidelines in oncology. Cancer- and chemotherapy- induced anemia:National comprehensive cancer network; 2014 [10/15/2016]. Available from:http://williams.medicine.wisc.edu/anemia.pdf.
79. Carson JL, Guyatt G, Heddle NM, et al. Clinical practice guidelines from the AABB:red blood cell transfusion thresholds and storage. Jama. 2016:Epub 2016/10/13.
80. Klein HG, Spahn DR, Carson JL. Red blood cell transfusion in clinical practice. Lancet (London, England). 2007;370:415–426. Epub 2007/08/07.
81. Wu WC, Rathore SS, Wang Y, et al. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med. 2001;345:1230–1236. Epub 2001/10/30.
82. Carson JL, Terrin ML, Noveck H, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med. 2011;365:2453–2462. Epub 2011/12/16.
83. Gregersen M, Borris LC, Damsgaard EM. Postoperative blood transfusion strategy in frail, anemic elderly patients with hip fracture:the TRIFE randomized controlled trial. Acta Orthop. 2015;86:363–372. Epub 2015/01/15.
84. Gregersen M, Damsgaard EM, Borris LC. Blood transfusion and risk of infection in frail elderly after hip fracture surgery:the TRIFE randomized controlled trial. Eur J Orthop Surg Traumatol. 2015;25:1031–1038. Epub 2015/02/19.
85. Gregersen M. Postoperative red blood cell transfusion strategy in frail anemic elderly with hip fracture. A randomized controlled trial. Dan Med J. 2016:63. Epub 2016/04/02.
86. Beyer I, Compte N, Busuioc A, et al. Anemia and transfusions in geriatric patients:a time for evaluation. Hematology. 2010;15:116–121. Epub 2010/04/29.
87. Sebastiani G, Wilkinson N, Pantopoulos K. Pharmacological targeting of the hepcidin/ferroportin axis. Front Pharmacol. 2016;7:160. Epub 2016/07/23.
88. Malyszko J, Malyszko JS. Emerging drugs for the treatment of kidney disease-induced anemia. Expert Opin Emerg Drugs. 2016;21:315–330. Epub 2016/08/19.
89. Perlstein TS, Pande R, Berliner N, et al. Prevalence of 25-hydroxyvitamin D deficiency in subgroups of elderly persons with anemia:association with anemia of inflammation. Blood. 2011;117:2800–2806. Epub 2011/01/18.
90. Zughaier SM, Alvarez JA, Sloan JH, et al. The role of vitamin D in regulating the iron-hepcidin-ferroportin axis in monocytes. J Clin Transl Endocrinol. 2014;1:19–25. Epub 2014/08/07.
91. Bacchetta J, Zaritsky JJ, Sea JL, et al. Suppression of iron-regulatory hepcidin by vitamin D. J Am Soc Nephrology:JASN. 2014;25:564–572. Epub 2013/11/10.